Acute respiratory tract infections represent a significant burden in primary care, with antibiotics often prescribed unnecessarily. This contributes to the escalating threat of antimicrobial resistance (AMR) by increasing the burden of infectious diseases and mortality risk. This is a report from a joint European Society of Clinical Microbiology and Infectious Diseases/European Respiratory Society research seminar held in November 2023 to discuss the role of in vitro diagnostic tests to combat AMR in community-acquired respiratory tract infections. We review the diagnostic tools available and in development, and the challenges related to their assessment, implementation in clinical settings and their overall impact on AMR.
Padilla, A. C. H., Viligorska, K., Ruiz, J. P. R., Traversi, L., Sanguinetti, M., Goossens, H., Polverino, E., In vitro diagnostics for respiratory infections: current state and opportunities, <<BREATHE>>, 2026; 22 (2): N/A-N/A. [doi:10.1183/20734735.0310-2025] [https://hdl.handle.net/10807/341379]
In vitro diagnostics for respiratory infections: current state and opportunities
Sanguinetti, Maurizio;
2026
Abstract
Acute respiratory tract infections represent a significant burden in primary care, with antibiotics often prescribed unnecessarily. This contributes to the escalating threat of antimicrobial resistance (AMR) by increasing the burden of infectious diseases and mortality risk. This is a report from a joint European Society of Clinical Microbiology and Infectious Diseases/European Respiratory Society research seminar held in November 2023 to discuss the role of in vitro diagnostic tests to combat AMR in community-acquired respiratory tract infections. We review the diagnostic tools available and in development, and the challenges related to their assessment, implementation in clinical settings and their overall impact on AMR.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
